Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07490769
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 years or older.
* diagnosed with uncontrolled Epilepsy of any type (defined as one or more unprovoked seizures in the last 6 months)
* On Levetiracetam monotherapy
* Participants must have a documented history of Levetiracetam use for at least 12 months prior to enrollment.
* on Levetiracetam high dose (1.5 - 3 g daily)
Exclusion Criteria:
* Younger than Aged 18 years
* Received Levetiracetam intravenous within the last 24hr.
* Co-administered with other antiepileptic drugs
* Received other antiepileptic drugs in the last two weeks.
* Pregnant women.
* Renal impairment (Crcl \< 30) or Acute kidney injury
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07490769
Study Brief:
Protocol Section:
NCT07490769